420 related articles for article (PubMed ID: 31615781)
1. Effectiveness of routine third trimester ultrasonography to reduce adverse perinatal outcomes in low risk pregnancy (the IRIS study): nationwide, pragmatic, multicentre, stepped wedge cluster randomised trial.
Henrichs J; Verfaille V; Jellema P; Viester L; Pajkrt E; Wilschut J; van der Horst HE; Franx A; de Jonge A;
BMJ; 2019 Oct; 367():l5517. PubMed ID: 31615781
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and cost-effectiveness of routine third trimester ultrasound screening for intrauterine growth restriction: study protocol of a nationwide stepped wedge cluster-randomized trial in The Netherlands (The IRIS Study).
Henrichs J; Verfaille V; Viester L; Westerneng M; Molewijk B; Franx A; van der Horst H; Bosmans JE; de Jonge A; Jellema P;
BMC Pregnancy Childbirth; 2016 Oct; 16(1):310. PubMed ID: 27737654
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Routine Third Trimester Ultrasound Screening for Fetal Growth Restriction Compared to Care as Usual in Low-Risk Pregnancies: A Pragmatic Nationwide Stepped-Wedge Cluster-Randomized Trial in The Netherlands (the IRIS Study).
Henrichs J; de Jonge A; Westerneng M; Verfaille V; Franx A; van der Horst HE; Bosmans JE; On Behalf Of The Iris Study Group
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329004
[TBL] [Abstract][Full Text] [Related]
4. Indicated vs universal third-trimester ultrasound examination in low-risk pregnancies: a pre-post-intervention study.
Roberts AW; Hotra J; Soto E; Pedroza C; Sibai BM; Blackwell SC; Chauhan SP
Am J Obstet Gynecol MFM; 2024 May; 6(5):101373. PubMed ID: 38583714
[TBL] [Abstract][Full Text] [Related]
5. Induction of labour at 41 weeks versus expectant management until 42 weeks (INDEX): multicentre, randomised non-inferiority trial.
Keulen JK; Bruinsma A; Kortekaas JC; van Dillen J; Bossuyt PM; Oudijk MA; Duijnhoven RG; van Kaam AH; Vandenbussche FP; van der Post JA; Mol BW; de Miranda E
BMJ; 2019 Feb; 364():l344. PubMed ID: 30786997
[TBL] [Abstract][Full Text] [Related]
6. Implication of third-trimester screening accuracy for small-for-gestational age and additive value of third-trimester growth-trajectory indicators in predicting severe adverse perinatal outcome in low-risk population: pragmatic secondary analysis of IRIS study.
van Roekel M; Henrichs J; Franx A; Verhoeven CJ; de Jonge A
Ultrasound Obstet Gynecol; 2023 Aug; 62(2):209-218. PubMed ID: 36704993
[TBL] [Abstract][Full Text] [Related]
7. Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP) study: a prospective cohort study.
Sovio U; White IR; Dacey A; Pasupathy D; Smith GCS
Lancet; 2015 Nov; 386(10008):2089-2097. PubMed ID: 26360240
[TBL] [Abstract][Full Text] [Related]
8. Routine third-trimester ultrasound in low-risk pregnancies and perinatal death: a systematic review and meta-analysis.
Al-Hafez L; Chauhan SP; Riegel M; Balogun OA; Hammad IA; Berghella V
Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100242. PubMed ID: 33345941
[TBL] [Abstract][Full Text] [Related]
9. Screening for small for gestational age infants in early vs late third-trimester ultrasonography: a randomized trial.
Verspyck E; Thill C; Ego A; Machevin E; Brasseur-Daudruy M; Ickowicz V; Blondel C; Degré S; Lefebure A; Braund S; Benichou J
Am J Obstet Gynecol MFM; 2023 Nov; 5(11):101162. PubMed ID: 37717697
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of third-trimester routine ultrasound in a non-selected population.
Skråstad RB; Eik-Nes SH; Sviggum O; Johansen OJ; Salvesen KÅ; Romundstad PR; Blaas HG
Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1353-60. PubMed ID: 24032741
[TBL] [Abstract][Full Text] [Related]
11. Prediction of small-for-gestational-age neonates at 35-37 weeks' gestation: contribution of maternal factors and growth velocity between 32 and 36 weeks.
Ciobanu A; Anthoulakis C; Syngelaki A; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2019 May; 53(5):630-637. PubMed ID: 30912210
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of fetal growth restriction in a cohort of small-for-gestational-age neonates at term: neonatal and maternal outcomes.
Pineles BL; Mendez-Figueroa H; Chauhan SP
Am J Obstet Gynecol MFM; 2022 Sep; 4(5):100672. PubMed ID: 35667554
[TBL] [Abstract][Full Text] [Related]
13. Associations of severe adverse perinatal outcomes among continuous birth weight percentiles on different birth weight charts: a secondary analysis of a cluster randomized trial.
Kamphof HD; Gordijn SJ; Ganzevoort W; Verfaille V; Offerhaus PM; Franx A; Pajkrt E; de Jonge A; Henrichs J
BMC Pregnancy Childbirth; 2022 Apr; 22(1):375. PubMed ID: 35490210
[TBL] [Abstract][Full Text] [Related]
14. The impact of a universal late third-trimester scan for fetal growth restriction on perinatal outcomes in term singleton births: A prospective cohort study.
Aderoba AK; Ioannou C; Kurinczuk JJ; Quigley MA; Cavallaro A; Impey L;
BJOG; 2023 Jun; 130(7):791-802. PubMed ID: 36660877
[TBL] [Abstract][Full Text] [Related]
15. Perinatal mortality and severe morbidity in low and high risk term pregnancies in the Netherlands: prospective cohort study.
Evers AC; Brouwers HA; Hukkelhoven CW; Nikkels PG; Boon J; van Egmond-Linden A; Hillegersberg J; Snuif YS; Sterken-Hooisma S; Bruinse HW; Kwee A
BMJ; 2010 Nov; 341():c5639. PubMed ID: 21045050
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of normalization of cerebro-placental ratio as a potential predictor for adverse outcome in SGA fetuses.
Monteith C; Flood K; Mullers S; Unterscheider J; Breathnach F; Daly S; Geary MP; Kennelly MM; McAuliffe FM; O'Donoghue K; Hunter A; Morrison JJ; Burke G; Dicker P; Tully EC; Malone FD
Am J Obstet Gynecol; 2017 Mar; 216(3):285.e1-285.e6. PubMed ID: 27840142
[TBL] [Abstract][Full Text] [Related]
17. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.
Duhig KE; Myers J; Seed PT; Sparkes J; Lowe J; Hunter RM; Shennan AH; Chappell LC;
Lancet; 2019 May; 393(10183):1807-1818. PubMed ID: 30948284
[TBL] [Abstract][Full Text] [Related]
18. Routine ultrasound screening in the third trimester: a population-based study.
Sylvan K; Ryding EL; Rydhstroem H
Acta Obstet Gynecol Scand; 2005 Dec; 84(12):1154-8. PubMed ID: 16305700
[TBL] [Abstract][Full Text] [Related]
19. Impact of point-of-care ultrasound and routine third trimester ultrasound on undiagnosed breech presentation and perinatal outcomes: An observational multicentre cohort study.
Knights S; Prasad S; Kalafat E; Dadali A; Sizer P; Harlow F; Khalil A
PLoS Med; 2023 Apr; 20(4):e1004192. PubMed ID: 37023211
[TBL] [Abstract][Full Text] [Related]
20. Induction of labour at 41 weeks versus expectant management and induction of labour at 42 weeks (SWEdish Post-term Induction Study, SWEPIS): multicentre, open label, randomised, superiority trial.
Wennerholm UB; Saltvedt S; Wessberg A; Alkmark M; Bergh C; Wendel SB; Fadl H; Jonsson M; Ladfors L; Sengpiel V; Wesström J; Wennergren G; Wikström AK; Elden H; Stephansson O; Hagberg H
BMJ; 2019 Nov; 367():l6131. PubMed ID: 31748223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
